TY - JOUR
T1 - Management of Patients With Refractory Angina
T2 - Canadian Cardiovascular Society/Canadian Pain Society Joint Guidelines
AU - McGillion, Michael
AU - Arthur, Heather M.
AU - Cook, Allison
AU - Carroll, Sandra L.
AU - Victor, J. Charles
AU - L'Allier, Philippe L.
AU - Jolicoeur, E. Marc
AU - Svorkdal, Nelson
AU - Niznick, Joel
AU - Teoh, Kevin
AU - Cosman, Tammy
AU - Sessle, Barry
AU - Watt-Watson, Judy
AU - Clark, Alexander
AU - Taenzer, Paul
AU - Coyte, Peter
AU - Malysh, Louise
AU - Galte, Carol
AU - Stone, James
N1 - Funding Information:
These guidelines were funded by the Canadian Institutes of Health Research , #188445 .
Funding Information:
Publication and distribution of this article are supported by Servier Canada and the Heart and Stroke Foundation of Ontario.
PY - 2012/3
Y1 - 2012/3
N2 - Refractory angina (RFA) is a debilitating disease characterized by cardiac pain resistant to conventional treatments for coronary artery disease including nitrates, calcium-channel and β-adrenoceptor blockade, vasculoprotective agents, percutaneous coronary interventions, and coronary artery bypass grafting. The mortality rate of patients living with RFA is not known but is thought to be in the range of approximately 3%. These individuals suffer severely impaired health-related quality of life with recurrent and sustained pain, poor general health status, psychological distress, impaired role functioning, and activity restriction. Effective care for RFA sufferers in Canada is critically underdeveloped. These guidelines are predicated upon a 2009 Canadian Cardiovascular Society (CCS) Position Statement which identified that underlying the problem of RFA management is the lack of a formalized, coordinated, interprofessional strategy between the cardiovascular and pain science/clinical communities. The guidelines are therefore a joint initiative of the CCS and the Canadian Pain Society (CPS) and make practice recommendations about treatment options for RFA that are based on the best available evidence. Concluding summary recommendations are also made, giving direction to future clinical practice and research on RFA management in Canada.
AB - Refractory angina (RFA) is a debilitating disease characterized by cardiac pain resistant to conventional treatments for coronary artery disease including nitrates, calcium-channel and β-adrenoceptor blockade, vasculoprotective agents, percutaneous coronary interventions, and coronary artery bypass grafting. The mortality rate of patients living with RFA is not known but is thought to be in the range of approximately 3%. These individuals suffer severely impaired health-related quality of life with recurrent and sustained pain, poor general health status, psychological distress, impaired role functioning, and activity restriction. Effective care for RFA sufferers in Canada is critically underdeveloped. These guidelines are predicated upon a 2009 Canadian Cardiovascular Society (CCS) Position Statement which identified that underlying the problem of RFA management is the lack of a formalized, coordinated, interprofessional strategy between the cardiovascular and pain science/clinical communities. The guidelines are therefore a joint initiative of the CCS and the Canadian Pain Society (CPS) and make practice recommendations about treatment options for RFA that are based on the best available evidence. Concluding summary recommendations are also made, giving direction to future clinical practice and research on RFA management in Canada.
UR - http://www.scopus.com/inward/record.url?scp=84858313344&partnerID=8YFLogxK
U2 - 10.1016/j.cjca.2011.07.007
DO - 10.1016/j.cjca.2011.07.007
M3 - Journal Article
C2 - 22424281
AN - SCOPUS:84858313344
SN - 0828-282X
VL - 28
SP - S20-S41
JO - Canadian Journal of Cardiology
JF - Canadian Journal of Cardiology
IS - 2 SUPPL.
ER -